• LOGIN
  • CONTACT US
  • enEnglish (English)
    • deDeutsch (German)
    • esEspañol (Spanish)
    • zh-hans简体中文 (Chinese (Simplified))
    • ja日本語 (Japanese)
    • pt-brPortuguês (Portuguese (Brazil))
    • heעברית (Hebrew)
    • ko한국어 (Korean)
    • frFrançais (French)
Arazy Group Consultants Inc.
  • Regulatory Solutions
    • LICENSALE®
    • REGISLATE®
    • Choose Your Regulatory Solution
    • Cost and Savings
    • European Regulatory Representative Services
  • 140 Countries
  • Resources
  • About Us
    • Webinars
    • Careers
Select Page

Unique Device Identifier (UDI) Submission as part of Pre-Market Requirements

by arazygroup | Jul 9, 2021 | Blog, Regulatory News Slider | 0 comments

Unique Device Identifier (UDI) Submission

As part of IMDRF Key Objectives 2021-2025 (Committee, 2020), the utilization of Unique Device Identifier (UDI) System is deemed as important to standardize information collected by regulators via post-market surveillance activities. The United States Food and Drug Administration (US FDA) and the European Commission are amongst countries who have initially established UDI regulations in 2013 and 2017, respectively (GS1, 2021).

The UDI system establishment and implementation, however, varies depending on the local infrastructure readiness and product classification. Most countries will be implementing the UDI system in phases starting with high-risk products.

The table below describes the UDI implementation status for several countries. Some countries also require the manufacturer to submit their UDI information as part of pre-market requirements.

References

Committee, I. M. (2020, September 25). International Medical Device Regulators Forum. Retrieved from International Medical Device Regulators Forum: http://www.imdrf.org/docs/imdrf/final/procedural/imdrf-proc-n39-strategic-plan-200925.pdf

EU, E. C. (2020, August 01). Unique Device Identifier – UDI. Retrieved from European Commission (EU): https://ec.europa.eu/health/sites/default/files/md_topics-interest/docs/md_faq_udi_en.pdf

GS1. (2021, June 29). Unique Device Identification (UDI). Retrieved from https://www.gs1.org/industries/healthcare/udi#udi-in-the-eu

HSA, H. S. (2021, May 25). Health Sciences Authority (HSA). Retrieved from Health Sciences Authority (HSA): https://www.hsa.gov.sg/docs/default-source/hprg-mdb/regulatory-updates/for-consult-guidance-on-udi-system-(25may_pub).pdf

MFDS, M. o. (2019, June 05). Ministry of Food and Drug Safety. Retrieved from Ministry of Food and Drug Safety: https://www.mfds.go.kr/eng/brd/m_40/view.do?seq=72620&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=1

NMPA, N. M. (2020, September 03). National Medical Products Administration. Retrieved from National Medical Products Administration: https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20200930165228171.html

SFDA, S. F. (2020, September 06). Saudi Food and Drug Authority. Retrieved from Saudi Food and Drug Authority: https://www.sfda.gov.sa/sites/default/files/2020-09/MDS-G34e.pdf

TFDA, T. F. (2020, November 05). Taiwan Food and Drug Administration. Retrieved from Taiwan Food and Drug Administration: https://www.fda.gov.tw/TC/newsContent.aspx?cid=5072&id=26490

 

Contact Us!

Arazy Group has over 25 years of regulatory expertise in medical devices and IVD devices.

Contact us at [email protected] for any inquiries or regulatory assistance. 

D

Search

Recent Posts

  • Malaysia – July 2022
  • Pakistan – July 2022
  • South Africa – June 2022
  • La Technologie des Dispositifs Médicaux
  • The Philippines- June 2022
  • Singapore- April 2022
  • Indonesia- March 2022
  • Malaysia- march 2022
  • The Philippines- Feb 2022
  • Malaysia Update – January 2022

Recent Comments

    Archives

    Categories

    • Application
    • Blog
    • Case Study
    • Documents
    • Homepage
    • Product Demo
    • Product Demo Slider
    • Products
    • Recent Registrations
    • Regulatory News
    • Regulatory News Slider
    • Regulatory Update
    • Regulatory Update Slider
    • Support
    • Top Story Slider
    • Uncategorized
    • Videos

    Arazy Group Consultants Inc. is an international consultancy spanning several continents, assisting medical and IVD device companies with regulatory compliance and affairs as they try to enter new markets

    Visit Us On FacebookVisit Us On TwitterVisit Us On Linkedin

    Regulatory Solutions

    • LICENSALE
    • REGISLATE
    • European Regulatory Representative Services
    • Resources
    • Privacy Policy
    • ISO 9001 Certificate

    Head Office

    #200-1333 Johnston St., Granville Island,
    Vancouver, BC V6H 3R9

    PHONE: +1 604.681.6888
    FAX: +1 604.681.6822
    [email protected]

    © Arazy Group Consultants Inc. - is an international consultancy spanning several continents, assisting medical and IVD device companies with regulatory compliance and affairs as they try to enter new markets
    ???

    We are using cookies to give you the best experience on our website.

    You can find out more about which cookies we are using or switch them off in settings.

    Arazy Group Consultants Inc.
    Powered by  GDPR Cookie Compliance
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

    Strictly Necessary Cookies

    Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

    If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

    Security_overview - Privacy Policy